Tag: #Global Trends

Pharmaceutical giant Eli Lilly and technology firm NVIDIA have disclosed a collaboration to construct a new supercomputing system. The project... Read more

The United Kingdom and the United States have reached a bilateral agreement to maintain zero tariffs on UK pharmaceutical shipments... Read more

The U.S. Food and Drug Administration (USFDA) has approved an updated label for Unloxcyt (cosibelimab-ipdl) for the treatment of adults... Read more

A pharmaceutical company has announced that it secured tentative approval from the United States Food and Drug Administration (USFDA) for... Read more

In light of substantial recent investments in oncology and mounting competition, a leading pharmaceutical corporation is seeking a new approach... Read more

The U.S. Food and Drug Administration (FDA) has granted approval for the use of Durvalumab (an immunotherapy) in combination with... Read more

A pharmaceutical corporation has submitted a supplemental application for a higher dose semaglutide injectable (7.2 mg) to the U.S. Food... Read more

The recent decisions by a leading Swiss pharmaceutical group highlight a broader trend within the industry: prioritizing automation, advanced manufacturing... Read more

On November 24, 2025, in Basel, Sandoz, a global leader in affordable medicines, announced the European launch of Afqlir® (aflibercept).... Read more